Medrad Inc.

Medrad Inc.

File:Medrad Logo.png

Type	Subsidiary
Key people	M. Stephen Heilman (Founder)
Industry	Medical Devices
Products	Medical imaging devices, contrast injection systems

Medrad Inc. is a prominent company in the field of medical imaging and radiology, known for its innovative products that enhance the quality and efficiency of diagnostic imaging procedures. Founded in 1964 by M. Stephen Heilman, Medrad has been at the forefront of developing advanced contrast injection systems and other medical devices that are crucial in modern healthcare.

History

Medrad was established in 1964 by M. Stephen Heilman, a pioneer in the field of medical imaging. The company initially focused on developing products that improved the safety and effectiveness of angiography procedures. Over the years, Medrad expanded its product line to include a wide range of devices used in magnetic resonance imaging (MRI), computed tomography (CT), and ultrasound imaging.

In 2006, Medrad was acquired by Bayer AG, a global leader in healthcare and pharmaceuticals. This acquisition allowed Medrad to leverage Bayer's extensive resources and global reach, further enhancing its ability to innovate and deliver high-quality products to healthcare providers worldwide.

Products

Medrad is best known for its contrast injection systems, which are used to deliver contrast agents during imaging procedures. These systems are essential for enhancing the visibility of internal structures in MRI and CT scans, allowing for more accurate diagnosis and treatment planning.

Some of Medrad's notable products include:

• Stellant CT Injection System: A state-of-the-art injector that provides precise control over the delivery of contrast media during CT scans.
• Spectris Solaris EP MR Injection System: Designed for use in MRI procedures, this system ensures consistent and reliable delivery of contrast agents.
• Intego PET Infusion System: A specialized system for the delivery of radiopharmaceuticals in positron emission tomography (PET) imaging.

Innovations and Impact

Medrad has been recognized for its commitment to innovation and quality. The company's products have significantly improved the safety and efficacy of diagnostic imaging procedures, leading to better patient outcomes. Medrad's technologies have also contributed to the advancement of personalized medicine by enabling more precise imaging and diagnosis.

Acquisition by Bayer

The acquisition of Medrad by Bayer AG in 2006 marked a significant milestone in the company's history. As a subsidiary of Bayer, Medrad has continued to thrive, benefiting from Bayer's global infrastructure and expertise in healthcare. This partnership has allowed Medrad to expand its product offerings and reach new markets, solidifying its position as a leader in the medical imaging industry.

Also see

• Medical Imaging
• Radiology
• Contrast Media
• Bayer AG
• M. Stephen Heilman

Template:Medical Device Companies [[{{{1}}}{{{2}}} {{{3}}}|{{{1}}}^{{{2}}} {{{3}}}]]